AI Chat Paper
Note: Please note that the following content is generated by AMiner AI. SciOpen does not take any responsibility related to this content.
{{lang === 'zh_CN' ? '文章概述' : 'Summary'}}
{{lang === 'en_US' ? '中' : 'Eng'}}
Chat more with AI
PDF (1.6 MB)
Collect
Submit Manuscript AI Chat Paper
Show Outline
Outline
Show full outline
Hide outline
Outline
Show full outline
Hide outline
Research Article | Open Access

In Vivo Genotoxicity of Gold Nanorods in Mouse Bone Marrow Compared with Cyclophosphamide

Amira M. Gamal-Eldeen1,2( )Mona A.M. Abo-Zeid2,3( )Sherien M. El-Daly1,4Mahmoud T. Abo-Elfadl1,2Cinderella A. Fahmy1,2Moustafa R.K. Ali5,6Mostafa A. El-Sayed6
Biochemistry Department, National Research Centre (NRC), Dokki 12622, Cairo, Egypt
Cancer Biology and Genetics Laboratory, Center of Excellence for Advanced Sciences, NRC
Genetics and Cytology Department, National Research Centre, Cairo, Egypt
Department of Medical Biochemistry, National Research Centre, Cairo, Egypt
Advanced Material Sciences and Nanotechnology Laboratory, Centre of Excellence for Advanced Sciences, NRC, Cairo, Egypt
Laser Dynamics Laboratory, School of Chemistry and Biochemistry, Georgia Institute of Technology, Atlanta, GA 30332-0400, USA
Show Author Information

Abstract

Gold nanorods (GNRs) are now under extensive investigation for biomedical applications. The in vivo genotoxic profile GNRs are not elucidated yet, therefore we investigated it in comparison with one of the most effective chemotherapeutic agents, cyclophosphamide (CP), in a mice model. PEGylated-GNRs (50 nm) were injected to Balb/C mice triple times, while CP-treated mice were treated once and the bone marrow cells (BMCs) were collected after 21 days. Chromosome aberrations, mitotic index, sister chromatid exchanges (SCEs), replicative index, micronucleus (MN) and DNA damage using comet assay were investigated. GNRs induced chromosome aberrations including- and excluding-gaps significantly at p < 0.001 and p < 0.01, respectively, however CP resulted in a higher significant increase in both types with p < 0.001. The percentage of SCEs / cell was not affected by GNRs treatment, while it was extremely significant with CP. Both mitotic activity and proliferative index were reduced dramatically with both of GNRs and CP. The recorded MN were lower in GNRs- than CP-treated mice. The percentage DNA damage, tail length and tail moment were higher in CP than GNRs. In conclusion, CP induced extreme genotoxicity more than GNRs. Both of GNRs and CP induced DNA damage. The study indicated the advantage of lower GNRs genotoxicity than that of CP. After 21 days, one injection of CP led to extreme persistent genotoxic effect more than that of multiple injections of GNRs.

References

[1]

S.K. Sahoo, S. Parveen, and J.J. Panda, The present and future of nanotechnology in human health care. Nanomedicine, 2007, 3(1): 20-31.

[2]

P. Rivera Gil, D. Hühn, L.L. del Mercato, et al., Nanopharmacy: Inorganic nanoscale devices as vectors and active compounds. Pharmacological Research, 2010, 62(2): 115-125.

[3]

N. Khlebtsov, L. Dykman, Biodistribution and toxicity of engineered gold nanoparticles: a review of in vitro and in vivo studies. Chemical Society Reviews, 2011, 40(3): 1647-1671.

[4]

H.J. Johnston, G. Hutchison, F.M. Christensen, et al., A review of the in vivo and in vitro toxicity of silver and gold particulates: particle attributes and biological mechanisms responsible for the observed toxicity. Critical Reviews in Toxicology, 2010, 40(4): 328-346.

[5]

A. Gerber, M. Bundschuh, D. Klingelhofer, et al., Gold nanoparticles: recent aspects for human toxicology. Journal of Occupational Medicine and Toxicology, 2013, 8(1): 32-37.

[6]

I.M. Paino, V.S. Marangoni, C. de Oliveira Rde, et al., Cyto and genotoxicity of gold nanoparticles in human hepatocellular carcinoma and peripheral blood mononuclear cells. Toxicology Letter, 2012, 215(2): 119-125.

[7]

N. Singh, B. Manshian, G.J. Jenkins, et al., Nano Genotoxicology: the DNA damaging potential of engineered nanomaterials. Biomaterials, 2009, (23-24): 3891-3914.

[8]

M. Schulz, L. Ma-Hock, S. Brill, et al., Investigation on the genotoxicity of different sizes of gold nanoparticles administered to the lungs of rats. Mutation Research, 2012, 745(1-2): 51-57.

[9]

J.J. Li, S.L. Lo, C.T. Ng, , et al., Genomic instability of gold nanoparticle treated human lung fibroblast cells. Biomaterials, 2011, 32(23): 5515-5523.

[10]

S.J. Soenen, P. Rivera-Gil, J. Montenegro, et al., Cellular toxicity of inorganic nanoparticles: Common aspects and guidelines for improved nanotoxicity evaluation. Nano today, 2011, 6(5): 446–465.

[11]

B. Gabrielli, K. Brooks, and S. Pavey. Defective cell cycle checkpoints as targets for anti-cancer therapies. Frontiers in Pharmacology., 2012, 3(9): 9.1-9.6.

[12]

D. Anderson, J.B. Bishop, R.C. Garner, et al., Cyclophosphamide: review of its mutagenicity for an assessment of potential germ cell risks. Mutation Research, 1995, 330(1-2): 115-181.

[13]

B. Nikoobakht, M.A. El-Sayed, Surface-Enhanced raman scattering studies on aggregated gold nanorods. The Journal of Physical Chemistry A, 2003, 107:3372–3378.

[14]

T.H. Yosida, K. Amano, Autosomal polymorphism in laboratory bred and wild Norway rats, Rattus norvegicus. Misima Chromosoma, 1965, 16: 658- 667.

[15]

J.W. Allen, E. El-Nahass, M.K. Sanyal, et al., Sister-chromatid exchange analyses in rodent maternal, embryonic and extra-embryonic tissues: transplacental and direct mutagen exposures. Mutation Research, 1981, 80(2): 297-311.

[16]

P. Perry, S. Wolff, New Giemsa method for the differential staining of sister chromatids. Nature (London), 1974, 251: 156-158.

[17]

E.L. Schneider, J Lewis, Aging and sister chromatid exchange. Ⅷ. Effect of environment on sister chromatid exchange induction and cell cycle kinetics on Ehrlich ascites tumor cells. Mechanisms of Ageing and Development, 1981, 17:327-330.

[18]

W. Schmid, The micronucleus test. Mutation Research, 1975, 31: 9-15.

[19]

W. Schlörmann, M.Glei, Comet fluorescence in situ hybridization (Comet-FISH): Detection of DNA damage. Cold Spring Harbor Protocols, 2009, 4: 1–6.

[20]

D. Chorvatovicová, J. Sandula, Effect of carboxymethyl-chitinglucan on cyclophosphamide induced mutagenicity. Mutation Research, 1995, 346: 43-48.

[21]

F.R. Morre, G.A. Urda, and G. Krishna, An in vivo/in vitro method for assessing micronucleus and chromosome aberration induction in rat bone marrow and spleen 1. Studies with cyclophosphamide. Mutation Research, 1995, 335: 191-199.

[22]

S.A. Moallem, B.F. Hales, The role of p53 and cell death by apoptosis and necrosis in 4-hydroperoxycyclophosphamide-induced limb malformations. Development, 1998, 125: 3225-3234.

[23]

M. Murata, T.Suzuki, and K. Midorikawa, Oxidative DNA damage by a hydroperoxide derivative of cyclophosphamide. Free Radical Biology & Medicine, 2004, 37: 793-802.

[24]
S.C. Gad, In Vitro Toxicology, 2nd edition, Taylor & Francis, 2000.
[25]

F.U. Alkan, C. Anlas, S. Cinar, et al., Effects of curcumin in combination with cyclophosphamide on canine mammary tumour cell lines. Veterinarni Medicina, 2014, 59(11): 553–572.

[26]

E.E. Connor, J. Mwamuka, A. Gole, et al., Gold nanoparticles are taken up by human cells but do not cause acute cytotoxicity. Small, 2005, 1(3): 325–327.

[27]

S. Singh, V. D'Britto, A.A. Prabhune, et al., Cytotoxic and genotoxic assessment of glycolipid-reduced and-capped gold and silver nanoparticles. New Journal of Chemistry, 2010, 34: 294–301.

[28]

H.K. Patra, S. Banerjee, U. Chaudhuri, et al., Cell selective response to gold nanoparticles. Nanomedicine: Nanotechnology, Biology, and Medicine, 2007, 3 (2): 111–119.

[29]

N. Pernodet, X.H. Fang, Y. Sun, et al., Adverse effects of citrate/gold nanoparticles on human dermal fibroblasts. Small, 2006, 2(6): 766–773.

[30]

N. Lewinski, V. Colvin, and R. Drezek, Cytotoxicity of nanoparticles. Small 2008, 4(1): 26–49.

[31]

M.A.M. Abo-Zeid, T. Liehr, M. Glei, et al., Detection of Cyto- and Genotoxicity of Rod-Shaped Gold Nanoparticles in Human Blood Lymphocytes Using Comet-FISH. Cytologia, 2015, 80(2): 173–181.

[32]

M.A.M. Abo-Zeid, T. Liehr, A.M. Gamal-Eldeen, et al., Potential of rod, sphere and semi-cube shaped gold nanoparticles to induce cytotoxicity and genotoxicity in human blood lymphocytes in vitro. European Journal of Nanomedicine, 2015, 7(1): 63–75.

[33]

T.K. Muller, P. Kasper, and L. Muller, Evaluation studies on the in vitro rat hepatocyte micronucleus assay. Mutation Research, 1995, 335: 293-307.

[34]

M. Fenech, The in vitro micronucleus technique. Mutation Research, 2000, 445: 81-95.

[35]

V. Martinez, A. Creus, W. Venegas, et al., Micronuclei assessment in buccal cells of people environmentally exposed to arsenic in northern Chile. Toxicology Letters, 2005, 155: 319-327.

[36]

J. Grigg, A. Tellabati, S. Rhead, et al., DNA damage of macrophages at an air-tissue interface induced by metal nanoparticles. Nanotoxicology, 2009, 3(4): 348–354.

[37]

M. Tsoli, H. Kuhn, W. Brandau, et al., Cellular uptake and toxicity of Au55 clusters. Small, 2005, 1:841–844.

[38]
Y. Zhao, H.S. Nalwa, Nanotoxicology– Interactions of Nanomaterials with Biological Systems. American Scientific Publishers, 2007.
[39]

B. Kang, M.A. Mackey, and M.A. El-Sayed, Nuclear targeting of gold nanoparticles in cancer cells induces DNA damage, causing cytokinesis arrest and apoptosis. Journal of the American Chemical Society, 2010, 132: 1517-1519.

[40]

W.-H. Chen, J.-X. Chen, H Cheng, et al., A new anti-cancer strategy of damaging mitochondria by pro-apoptotic peptide functionalized gold nanoparticles. Chemical Communications (Camb), 2013, 49: 6403-6405.

[41]

J.J. Li, L. Zou, D. Hartono, et al., Gold nanoparticles induce oxidative damage in lung fibroblasts in vitro. Advanced Materials, 2008, 20(1): 138-142.

Nano Biomedicine and Engineering
Pages 306-314
Cite this article:
Gamal-Eldeen AM, Abo-Zeid MA, El-Daly SM, et al. In Vivo Genotoxicity of Gold Nanorods in Mouse Bone Marrow Compared with Cyclophosphamide. Nano Biomedicine and Engineering, 2016, 8(4): 306-314. https://doi.org/10.5101/nbe.v8i4.p306-314

455

Views

16

Downloads

1

Crossref

4

Scopus

Altmetrics

Received: 14 December 2016
Accepted: 27 December 2016
Published: 29 December 2016
© 2016 Amira M. Gamal-Eldeen, Mona A.M. Abo-Zeid, Sherien M. El-Daly, Mahmoud T. Abo-Elfadl, Cinderella A. Fahmy, Moustafa R. K. Ali, and Mostafa A. El-Sayed.

This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Return